The stock price of the skilled nursing facilities provider tumbled by over 8% on June 8, followed by an additional 3% drop on June 11, after the reports surfaced. Analysts at Hunterbrook alleged that Ensign’s profitability relies on reducing patient care and cutting staff at newly acquired facilities, despite public claims that the company prioritizes quality outcomes. Muddy Waters Research bolstered these claims by alleging that the company uses "rented" nursing home administrators who are rarely present at facilities, potentially constituting fraud against Medicare and Medicaid. Hagens Berman partner Reed Kathrein stated the firm is now scrutinizing whether Ensign misled shareholders regarding its regulatory compliance and accounting practices. The potential legal exposure is significant, with Muddy Waters estimating that theoretical sanctions under the False Claims Act could reach into the billions of dollars if the alleged practices are proven widespread.